HWG Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

HWG Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-40,467	Closed	-$1M	–	32
2016 Q3	$1M	Buy	+40,467	New	+$916K	1.05%	27

Other funds holding SUPN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HWG Holdings's SUPN Position: Q4 2016 in Review

HWG Holdings sold out of Supernus Pharmaceuticals (SUPN) in Q4 2016, closing a stake of 40,467 shares — an estimated $1M sold.

HWG Holdings first reported a position in SUPN in Q3 2016 and held it in 1 quarter. The position peaked at $1M in Q3 2016. 233 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

HWG Holdings reported no remaining Supernus Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
HWG Holdings sold 40,467 Supernus Pharmaceuticals shares in Q4 2016, an estimated $1M.
HWG Holdings first reported a position in Supernus Pharmaceuticals in Q3 2016 and held it in 1 quarter.
HWG Holdings's Supernus Pharmaceuticals position peaked at $1M in Q3 2016.
233 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on HWG Holdings's 13F filing for Q4 2016, filed 21 Feb 2017.